Bio-IT World Conference + Expo to Explore the Venture Capital Landscape for Bio-IT and Biopharma Industries
FRAMINGHAM, MA – APRIL 13, 2005 – IDG World Expo, the leading producer of world-class tradeshows, conferences and events for technology markets, today announced the agenda for the "Venture Forum" at Bio-IT World Conference + Expo(R). Also announced is the addition of Lawrence J. Lesko of the Food and Drug Administration (FDA) to the already impressive keynote lineup at the 4th annual event to be held at the Hynes Convention Center in Boston, May 17-19, 2005.
Hosted by Ernst & Young and IDG Ventures, the "Venture Forum" unites the bio-IT and biopharma industries as no gathering before. This one-day event on Thursday, May 19, 2005 will provide informed, in-depth analysis on the investment landscape for both the biotech and biopharma technology industries. The forum will give attendees a clearer understanding of where the life science research and drug discovery markets are heading, where monies are being invested, and the organizations that are positioning themselves to be the future drivers of these technological advances.
Lawrence J. Lesko, PhD, FCP, director, Office of Clinical Pharmacology and Biopharmaceutics in the FDA's Center for Drug Evaluation and Research will present his keynote address titled, "Pharmacogenomics, Personalized Medicine and the Role of FDA" on Wednesday, May 18, 2005. In his talk, he will outline the new portfolio of FDA guidances on pharmacogenomics and share his views on key issues and challenges in using pharmacogenomics to improve the success of drug development and to improve the benefit/risk ratio of drugs through personalized medicine.
In addition to his role as director, Dr. Lesko also chairs or co-chairs several FDA Working Groups which are developing guidances on pharmacogenomics for the industry, including the Genomic Date Submission Guidance. The keynote list at Bio-IT World already includes two of the most prestigious scientists in their respective fields. J. Craig Venter, PhD, president of the J. Craig Venter Institute, pioneered the mapping of the human genome. Tim Berners-Lee, director of the World Wide Web Consortium, invented the World Wide Web.
The Venture Forum agenda will provide participants with an understanding of where the markets are heading, where money is being invested, and what organizations are positioning themselves to drive future technological advances.
"Participants at this year's Bio-IT World Venture Forum will once again be able to get the latest insights on the venture funding environment for companies in this sector, together with a current perspective of the needs of buyers of their technology for bio-IT and biopharma Industries," said Bryan Pearce, partner in the Venture Capital Advisory Group at Ernst & Young.
Pearce will kick-off the Venture Forum with an overview of some of the year's developments in the life sciences industries including results from Ernst & Young's annual Biotechnology research, Global Pharmaceutical Report, Life Sciences venture funding update in conjunction with VentureOne and the results of the latest life sciences Compensation Survey.
James Golden, Ph.D. of SAIC's Life Science Office will present an overview of the pharmaceutical IT landscape. He will discus how in an effort to increase pharmaceutical productivity and decrease attrition, biopharmaceutical companies are examining and re-engineering every process in the R&D value chain. Golden will explore evolving information technologies that will act as focal points for R&D optimization and will size the opportunity and identify the best areas for near-term commercial growth.
"The Venture Forum will provide keen insight into the history and issues of the hottest emerging industry areas," said Michael A. Greeley, founder, managing general partner, IDG Ventures. "During one portion of the program, we've developed several roundtable discussions in the areas of Bio-IT, Health-IT, Clinical Trials and Emerging Technologies – moderated by industry leaders who will share their perspectives of the industry followed by introductions to 16 emerging companies in this space. Consider this your mini tutorial for the biotech and biopharma space."
In the "Buyer's Panel," technology buyers from pharmaceutical and biotechnology companies will share their strategies for evaluating their options. They will discuss what they think is important when evaluating the tools and solutions that promise to help them accelerate their research and development. The panel will consist of a cross section of senior level, major end-users at organizations across the life science and healthcare space and will be moderated by Alan Bergstein, president & publisher, Bio-IT World magazine.
For the complete schedule or to register for Bio-IT World Conference + Expo, visit www.bio-itworldexpo.com .
About Bio-IT World Conference + Expo
Bio-IT World Conference + Expo is the leading event to demonstrate how technology is transforming the life sciences throughout all discovery and development processes. Bio-IT World Conference + Expo is designed for life science professionals looking to evaluate and understand advanced solutions that generate, collect and analyze the flood of information being produced by the life sciences industry. Visionaries from the biotechnology, pharmaceutical, healthcare, academic and government markets convene at Bio-IT World Conference + Expo to learn how the latest tools, services and best practices will help revolutionize our health, our environment and our society. For more information, visit www.bio-itworldexpo.com .
About Bio-IT World, Inc.
A business unit of IDG, Bio-IT World, Inc., publishes information across a variety of media to meet the needs of bio-IT, life science, healthcare, pharmaceutical and regulatory professionals. The company's award-winning publication, Bio-IT World, and accompanying website, www.bio-itworld.com , deliver the latest news, analysis and information on the application of technology products and services to enable the life sciences R&D value chain – spanning basic research, drug discovery and development, clinical trials, and regulatory compliance. Additionally, the company's weekly electronic publication, Health-IT World News, cover business, technology and product developments related to healthcare management systems and outcomes-based medicine. Established in September 2001, Bio-IT World, Inc. is headquartered in Framingham, Mass.
About IDG World Expo
IDG World Expo ( www.idgworldexpo.com ) produces technology-focused tradeshows, conferences and events for professionals seeking world-class education, peer-to-peer networking and one-stop comparison shopping. As the leading technology event management company, IDG World Expo leverages its experience and knowledge of technology-focused events and conferences, enabling technology companies to capture the attention and loyalty of influential buyers. IDG World Expo's portfolio of conferences and events includes Macworld Conference & Expo(R), LinuxWorld Conference & Expo(R), Bio-IT World Conference + Expo(R), Wireless Sensing Solutions(R), Syndicate(TM), RoboBusiness and RoboNexus. IDG World Expo is a business unit of IDG, the world's leading technology media, research and event company.
International Data Group (IDG) is the world's leading technology media, research, and event company. A privately-held company, IDG publishes more than 300 magazines and newspapers including Bio-IT World, CIO, CSO, Computerworld, GamePro, InfoWorld, Network World, and PC World. The company features the largest network of technology-specific Web sites with more than 400 around the world. IDG is also a leading producer of more than 170 computer-related events worldwide including LinuxWorld Conference & Expo(R), Macworld Conference & Expo(R), DEMO(R), and IDC Directions. IDC provides global market research and advice through offices in 50 countries. Company information is available at http://www.idg.com .